Oh Oh !
Ask yourself why is Platinum ( Biotech Fund ) still a major shareholder in Anp if Atl1102 is not compelling and you don’t think much of the Science:?
Tell me . Sarepta and another 3 Pharmas involved in DMD ( none of them can offer a cure) All these 4 Pharmas will need Anp ( Atl1102)for combination therapy.
There is no drug for Limb Girdle
Atl1102 could be the first to treat LG .
Thank you for acknowledging that it’s the market that is destroying shareholder wealth.
There will be many mining stocks that won’t survive : Raising $$$ very difficult .
Diamond’s last day at ANP, page-32
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
-0.046(34.1%) |
Mkt cap ! $80.23M | |||
| Open | High | Low | Value | Volume |
| 8.7¢ | 9.0¢ | 8.6¢ | $2.082M | 23.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 250808 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 312804 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |